查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954676

全球輻射劑量管理市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測（2026-2034）

Radiation Dose Management Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 請詢問到貨日

價格

輻射劑量管理市場的成長驅動因素

全球輻射劑量管理市場正經歷顯著成長，其成長動力主要來自診斷影像程序的增加、日益嚴格的病患安全法規以及先進輻射技術的廣泛應用。根據2025年報告分析，2025年全球市場規模為8.542億美元，預計2026年將成長至9.733億美元。預計2026年至2034年，該市場將以15.10%的強勁年複合成長率成長，到2034年達到30.04億美元。

北美在2025年佔據全球市場主導地位，市場佔有率達39.10%，這得益於其完善的監管框架、高診斷成像量以及對先進劑量監測軟體的早期應用。

市場概覽

輻射劑量管理是指目的是監測、追蹤和最佳化醫學影像診斷過程（例如CT掃描、X光、透視和核子醫學檢查）中輻射暴露的解決方案和軟體系統。這些系統幫助醫療機構在確保符合安全準則的前提下，獲得高品質的診斷影像。

全球診斷影像程序數量的不斷成長以及人們對輻射相關健康風險日益增強的認識，是推動劑量管理解決方案需求的主要因素。主要產業參與者之間的策略聯盟進一步加速市場擴張。例如，領先企業與劑量管理解決方案提供者之間的合作促進技術整合和工作流程最佳化。

新冠疫情的影響

新冠疫情對輻射劑量管理市場產生了正面影響。用於新冠病毒診斷的CT掃描激增，導致全球診斷影像量顯著增加。由於CT影像使用電離輻射，醫院加快了劑量監測解決方案的採用，以確保病患安全和符合監管要求。

CT掃描使用量的增加帶動了影像設備銷售的成長，進而推動了對整合輻射劑量管理軟體的需求。市場在2022年全面復甦，此後一直保持強勁的成長動力。

主要市場趨勢

人工智慧（AI）的整合

影響市場發展的關鍵趨勢之一是將人工智慧（AI）整合到放射學領域。 AI 演算法有助於：

  • 最佳化影像處理方案
  • 改進影像重建
  • 預測每位病患的輻射暴露量
  • 增強風險預測模型

隨著 AI 的不斷發展，劑量最佳化策略和個人化成像方法的支援預計將進一步改進，這將顯著推動市場成長，直至2034年。

市場成長驅動因素

1.嚴格的輻射安全法規

國際原子能總署（IAEA）等國際組織和歐洲監管機構已製定了嚴格的電離輻射安全標準。為減少不必要的輻射暴露，特別是孕婦和兒童等弱勢群體的輻射暴露，監管壓力不斷加大，這推動了劑量管理軟體的普及應用。

2.影像技術的進步

CT 掃描儀、迭代重建演算法和影像軟體的持續進步，在提高影像品質的同時，也降低了輻射暴露。供應商發布升級版的劑量管理平台，這些平台具備更強大的分析和監測功能，加速市場滲透。

限制因子

儘管成長前景廣闊，但仍存在以下挑戰：

  • 影像系統和劑量管理軟體成本高昂
  • 中低收入國家醫療基礎設施不足
  • 小型醫院和診斷中心預算有限

在許多發展中地區，電力供應不足和成像設施的限制阻礙了大規模部署。

市場區隔分析

依手術類型

市場區隔如下：

  • 電腦斷層掃描（CT）
  • 核子醫學
  • X射線和乳房X光檢查
  • 透視與介入治療影像
  • 其他

X光檢查。乳房X光檢查佔據最大的市場佔有率，預計到2026年將佔市場佔有率的40.46%，這主要得益於X光檢查和乳癌篩檢的增加。

預計核醫領域將以最高的年複合成長率成長，這主要得益於全球PET和SPECT掃描數量的不斷成長。

依應用領域劃分

主要應用領域如下：

  • 腫瘤科
  • 骨科
  • 心臟科
  • 神經科
  • 其他

預計到2026年，骨科領域將佔據最大的市場佔有率，達到36.64%，這主要得益於創傷病例和運動損傷病例的增加，這些病例需要透視引導手術。

預計腫瘤科領域將實現最高的年複合成長率，這主要得益於癌症診斷和追蹤中重複CT掃描需求的不斷成長。

依最終使用者劃分

市場區隔如下：

  • 醫院和專科診所
  • 診斷中心
  • 其他

預計到2026年，診斷中心細分市場將以49.60%的市場佔有率引領市場，並在2034年之前維持最高的年複合成長率，這主要得益於門診影像檢查數量的增加。

區域洞察

北美

北美維持了其市場領先地位，2025年市場規模達到3.339億美元。預計到2026年，美國市場規模將達3.61億美元。這一成長得益於核醫學檢查的高水準開展以及強有力的監管執行。

歐洲

到2025年，歐洲佔據第二大市場佔有率，這主要得益於輻射安全訓練的加強和監管舉措的推進。德國和英國是該地區成長的主要貢獻者。

亞太地區

預計到2034年，亞太地區將以最高的年複合成長率成長。該地區的成長主要得益於醫療基礎設施的擴張和醫療支出的增加。

  • 預計2026年，日本市場規模將達到1.085億美元。
  • 預計2026年，中國市場規模將達到8,570萬美元。
  • 預計到2026年，印度市場規模將達到4,230萬美元。

其他地區（ROW）

由於基礎設施不足和醫療支出較低，其他地區的成長速度相對較慢。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要發現

  • 2025年主要國家和地區的電腦斷層掃描（CT）掃描量
  • 2025年主要國家和地區的磁振造影（MRI）掃描量
  • 主要產業趨勢（併購、合作、新產品發表等）
  • 新冠疫情的影響市場

第5章 全球輻射劑量管理市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依手術類型劃分
    • 電腦斷層掃描（CT）
    • 核子醫學
    • X射線和乳房X光檢查
    • 透視與介入性影像
    • 其他
  • 市場分析、洞察與預測：依應用領域劃分
    • 腫瘤科
    • 骨科
    • 心臟科
    • 神經科
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院和專科診所
    • 診斷中心
    • 其他
  • 市場分析、洞察與預測預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美輻射劑量管理市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲輻射劑量管理市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲地區

第8章 分析亞太地區輻射劑量管理市場：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太地區

第9章 拉丁美洲輻射劑量管理市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章 中東與非洲輻射劑量管理市場分析：洞察與預測（2021-2034）

  • 各國概覽
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市場佔有率分析（2025）
  • 公司簡介
    • Bayer AG
    • Siemens Healthineers AG
    • FUJIFILM Corporation
    • GE Healthcare
    • Koninklijke Philips N.V.
    • Bracco
    • Medsquare SAS
Product Code: FBI101228

Growth Factors of radiation dose management Market

The global radiation dose management market is witnessing significant growth driven by rising imaging procedures, strict patient safety regulations, and increasing adoption of advanced radiology technologies. According to the 2025 report analysis, the market was valued at USD 854.2 million in 2025 and is projected to grow to USD 973.3 million in 2026. The market is expected to reach USD 3,004.00 million by 2034, expanding at a robust CAGR of 15.10% during 2026-2034.

North America dominated the global market with a 39.10% share in 2025, supported by strong regulatory frameworks, high imaging volumes, and early adoption of advanced dose monitoring software.

Market Overview

Radiation dose management refers to solutions and software systems designed to monitor, track, and optimize radiation exposure during medical imaging procedures such as CT scans, radiography, fluoroscopy, and nuclear medicine. These systems help healthcare providers maintain compliance with safety guidelines while ensuring high-quality diagnostic imaging.

The growing number of imaging procedures globally, combined with increasing awareness of radiation-related health risks, is a primary factor fueling demand for dose management solutions. Strategic collaborations among key industry players are further strengthening market expansion. For instance, partnerships between leading imaging companies and dose management solution providers are accelerating technological integration and workflow optimization.

COVID-19 Impact

The COVID-19 pandemic had a positive impact on the radiation dose management market. The surge in CT scans for diagnosing COVID-19 significantly increased imaging volumes worldwide. Since CT imaging involves ionizing radiation, hospitals increasingly adopted dose monitoring solutions to ensure patient safety and regulatory compliance.

Higher CT utilization led to increased sales of imaging equipment, which in turn drove demand for integrated radiation dose management software. The market fully recovered by 2022 and has since resumed strong growth momentum.

Key Market Trends

Integration of Artificial Intelligence (AI)

A major trend shaping the market is the integration of Artificial Intelligence (AI) in radiology. AI-powered algorithms help:

  • Optimize imaging protocols
  • Improve image reconstruction
  • Predict patient-specific radiation doses
  • Enhance risk prediction models

As AI continues to evolve, it is expected to further improve dose optimization strategies and support personalized imaging approaches, significantly strengthening market growth through 2034.

Market Growth Drivers

1. Stringent Radiation Safety Regulations

Global organizations such as the International Atomic Energy Agency (IAEA) and European regulatory bodies have established strict safety standards for ionizing radiation. Growing regulatory pressure to reduce unnecessary radiation exposure-especially among vulnerable populations such as pregnant women and children-is driving widespread adoption of dose management software.

2. Technological Advancements in Imaging

Continuous advancements in CT scanners, iterative reconstruction algorithms, and imaging software are improving image quality while reducing radiation exposure. Vendors are launching upgraded versions of dose management platforms with enhanced analytics and monitoring capabilities, accelerating market penetration.

Restraining Factors

Despite strong growth prospects, certain challenges persist:

  • High costs associated with imaging systems and dose management software
  • Limited healthcare infrastructure in low- and middle-income countries
  • Budget constraints in smaller hospitals and diagnostic centers

In many developing regions, insufficient electricity supply and limited imaging facilities hinder large-scale adoption.

Market Segmentation Analysis

By Procedure

The market is segmented into:

  • Computed Tomography (CT)
  • Nuclear Medicine
  • Radiography & Mammography
  • Fluoroscopy & Interventional Imaging
  • Others

The Radiography and Mammography segment held the largest share and is expected to account for 40.46% of the market in 2026, driven by rising X-ray and breast cancer screening procedures.

The Nuclear Medicine segment is projected to grow at the highest CAGR due to increasing PET and SPECT scan volumes globally.

By Application

Key application areas include:

  • Oncology
  • Orthopedics
  • Cardiology
  • Neurology
  • Others

The Orthopedics segment held the largest share, accounting for 36.64% in 2026, supported by increasing trauma cases and sports injuries requiring fluoroscopic guidance.

The Oncology segment is anticipated to register the highest CAGR due to the growing need for repetitive CT scans for cancer diagnosis and monitoring.

By End User

The market is categorized into:

  • Hospitals & Specialty Clinics
  • Diagnostic Centers
  • Others

The Diagnostic Centers segment dominated with a 49.60% share in 2026 and is expected to grow at the highest CAGR through 2034, driven by increasing outpatient imaging volumes.

Regional Insights

North America

North America generated USD 333.9 million in 2025, maintaining market leadership. The U.S. market is projected to reach USD 361 million in 2026. Growth is supported by high nuclear medicine procedure volumes and strong regulatory enforcement.

Europe

Europe held the second-largest share in 2025, driven by increasing radiation safety training and regulatory initiatives. Germany and the UK are major contributors to regional growth.

Asia Pacific

Asia Pacific is projected to grow at the highest CAGR through 2034. The region's growth is fueled by expanding healthcare infrastructure and rising healthcare expenditure.

  • Japan market expected to reach USD 108.5 million in 2026
  • China market projected at USD 85.7 million in 2026
  • India market estimated at USD 42.3 million in 2026

Rest of the World

Growth remains comparatively slower due to limited infrastructure and lower healthcare spending.

Competitive Landscape

Major players operating in the radiation dose management market include:

  • Siemens Healthineers AG
  • FUJIFILM Corporation
  • GE Healthcare
  • Bayer AG
  • Koninklijke Philips N.V.
  • Bracco
  • Medsquare SAS

These companies maintain strong positions through diversified product portfolios, technological innovation, strategic partnerships, and geographic expansion.

Conclusion

The global radiation dose management market is poised for strong expansion from USD 854.2 million in 2025 to USD 3,004.00 million by 2034, driven by increasing imaging volumes, AI integration, regulatory compliance requirements, and technological advancements. While cost and infrastructure challenges remain in developing regions, growing awareness of radiation safety and expanding diagnostic capabilities worldwide will continue to propel long-term market growth.

Segmentation By Procedure

  • Computed Tomography
  • Nuclear Medicine
  • Radiography and Mammography
  • Fluoroscopy and Interventional Imaging
  • Others

By Application

  • Oncology
  • Orthopedics
  • Cardiology
  • Neurology
  • Others

By End-user

  • Hospitals & Specialty Clinics
  • Diagnostic Centers
  • Others

By Geography

  • North America (By Procedure, By Application, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By Procedure, By Application, By End-user, and By Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Procedure, By Application, By End-user, and By Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Rest of the World (By Procedure, By Application, and By End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Computed tomography (CT) Exams, Key Countries/ Regions, 2025
  • 4.2. Number of Magnetic Resonance Imaging (MRI) Exams, Key Countries/ Regions, 2025
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
  • 4.4. Impact of COVID-19 in the Market

5. Global Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Procedure
    • 5.1.1. Computed Tomography
    • 5.1.2. Nuclear Medicine
    • 5.1.3. Radiography and Mammography
    • 5.1.4. Fluoroscopy and Interventional Imaging
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Oncology
    • 5.2.2. Orthopedics
    • 5.2.3. Cardiology
    • 5.2.4. Neurology
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals & Specialty Clinics
    • 5.3.2. Diagnostic Centers
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Procedure
    • 6.1.1. Computed Tomography
    • 6.1.2. Nuclear Medicine
    • 6.1.3. Radiography and Mammography
    • 6.1.4. Fluoroscopy and Interventional Imaging
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Oncology
    • 6.2.2. Orthopedics
    • 6.2.3. Cardiology
    • 6.2.4. Neurology
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospitals & Specialty Clinics
    • 6.3.2. Diagnostic Centers
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Procedure
    • 7.1.1. Computed Tomography
    • 7.1.2. Nuclear Medicine
    • 7.1.3. Radiography and Mammography
    • 7.1.4. Fluoroscopy and Interventional Imaging
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Oncology
    • 7.2.2. Orthopedics
    • 7.2.3. Cardiology
    • 7.2.4. Neurology
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospitals & Specialty Clinics
    • 7.3.2. Diagnostic Centers
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Procedure
    • 8.1.1. Computed Tomography
    • 8.1.2. Nuclear Medicine
    • 8.1.3. Radiography and Mammography
    • 8.1.4. Fluoroscopy and Interventional Imaging
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Oncology
    • 8.2.2. Orthopedics
    • 8.2.3. Cardiology
    • 8.2.4. Neurology
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospitals & Specialty Clinics
    • 8.3.2. Diagnostic Centers
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Procedure
    • 9.1.1. Computed Tomography
    • 9.1.2. Nuclear Medicine
    • 9.1.3. Radiography and Mammography
    • 9.1.4. Fluoroscopy and Interventional Imaging
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Oncology
    • 9.2.2. Orthopedics
    • 9.2.3. Cardiology
    • 9.2.4. Neurology
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospitals & Specialty Clinics
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Radiation Dose Management Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Procedure
    • 10.1.1. Computed Tomography
    • 10.1.2. Nuclear Medicine
    • 10.1.3. Radiography and Mammography
    • 10.1.4. Fluoroscopy and Interventional Imaging
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Oncology
    • 10.2.2. Orthopedics
    • 10.2.3. Cardiology
    • 10.2.4. Neurology
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospitals & Specialty Clinics
    • 10.3.2. Diagnostic Centers
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Bayer AG
      • 11.2.1.1. Overview
      • 11.2.1.2. Product
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. financials (Based on Availability)
    • 11.2.2. Siemens Healthineers AG
      • 11.2.2.1. Overview
      • 11.2.2.2. Product
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. financials (Based on Availability)
    • 11.2.3. FUJIFILM Corporation
      • 11.2.3.1. Overview
      • 11.2.3.2. Product
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. financials (Based on Availability)
    • 11.2.4. GE Healthcare
      • 11.2.4.1. Overview
      • 11.2.4.2. Product
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. financials (Based on Availability)
    • 11.2.5. Koninklijke Philips N.V.
      • 11.2.5.1. Overview
      • 11.2.5.2. Product
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. financials (Based on Availability)
    • 11.2.6. Bracco
      • 11.2.6.1. Overview
      • 11.2.6.2. Product
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. financials (Based on Availability)
    • 11.2.7. Medsquare SAS
      • 11.2.7.1. Overview
      • 11.2.7.2. Product
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. financials (Based on Availability)

List of Tables

  • Table 1: Global Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 2: Global Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 3: Global Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 4: Global Radiation Dose Management Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 5: North America Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 6: North America Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 7: North America Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 8: North America Radiation Dose Management Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 9: Europe Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 10: Europe Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 11: Europe Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: Europe Radiation Dose Management Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 14: Asia Pacific Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 16: Asia Pacific Radiation Dose Management Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 18: Latin America Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 19: Latin America Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 20: Latin America Radiation Dose Management Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Radiation Dose Management Market Revenue (USD million) Forecast, by Procedure, 2021-2034
  • Table 22: Middle East & Africa Radiation Dose Management Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 23: Middle East & Africa Radiation Dose Management Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 24: Middle East & Africa Radiation Dose Management Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Radiation Dose Management Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Radiation Dose Management Market Value Share (%), by Procedure, 2025 & 2034
  • Figure 3: Global Radiation Dose Management Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Radiation Dose Management Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Radiation Dose Management Market Value (USD million), by Region, 2025 & 2034
  • Figure 6: North America Radiation Dose Management Market Value (USD million), by Procedure, 2025 & 2034
  • Figure 7: North America Radiation Dose Management Market Value Share (%), by Procedure, 2025
  • Figure 8: North America Radiation Dose Management Market Value (USD million), by Application, 2025 & 2034
  • Figure 9: North America Radiation Dose Management Market Value Share (%), by Application, 2025
  • Figure 10: North America Radiation Dose Management Market Value (USD million), by End-user, 2025 & 2034
  • Figure 11: North America Radiation Dose Management Market Value Share (%), by End-user, 2025
  • Figure 12: North America Radiation Dose Management Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America Radiation Dose Management Market Value Share (%), By Country, 2025
  • Figure 14: Europe Radiation Dose Management Market Value (USD million), by Procedure, 2025 & 2034
  • Figure 15: Europe Radiation Dose Management Market Value Share (%), by Procedure, 2025
  • Figure 16: Europe Radiation Dose Management Market Value (USD million), by Application, 2025 & 2034
  • Figure 17: Europe Radiation Dose Management Market Value Share (%), by Application, 2025
  • Figure 18: Europe Radiation Dose Management Market Value (USD million), by End-user, 2025 & 2034
  • Figure 19: Europe Radiation Dose Management Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Radiation Dose Management Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Radiation Dose Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Radiation Dose Management Market Value (USD million), by Procedure, 2025 & 2034
  • Figure 23: Asia Pacific Radiation Dose Management Market Value Share (%), by Procedure, 2025
  • Figure 24: Asia Pacific Radiation Dose Management Market Value (USD million), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Radiation Dose Management Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Radiation Dose Management Market Value (USD million), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Radiation Dose Management Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Radiation Dose Management Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Radiation Dose Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Radiation Dose Management Market Value (USD million), by Procedure, 2025 & 2034
  • Figure 31: Latin America Radiation Dose Management Market Value Share (%), by Procedure, 2025
  • Figure 32: Latin America Radiation Dose Management Market Value (USD million), by Application, 2025 & 2034
  • Figure 33: Latin America Radiation Dose Management Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Radiation Dose Management Market Value (USD million), by End-user, 2025 & 2034
  • Figure 35: Latin America Radiation Dose Management Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Radiation Dose Management Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Radiation Dose Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Radiation Dose Management Market Value (USD million), by Procedure, 2025 & 2034
  • Figure 39: Middle East & Africa Radiation Dose Management Market Value Share (%), by Procedure, 2025
  • Figure 40: Middle East & Africa Radiation Dose Management Market Value (USD million), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Radiation Dose Management Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Radiation Dose Management Market Value (USD million), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Radiation Dose Management Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Radiation Dose Management Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Radiation Dose Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Radiation Dose Management Market Share (%), By Company, 2025